Proteomic analysis in lung tissue of smokers and COPD patients

Chest

Volumn 135, Issue 2, 2009, Pages 344-352

  Lee, Eun Joo ^a   In, Kwang Ho ^b   Kim, Je Hyeong ^a   Lee, Sang Yeub ^a   Shin, Chol ^a   Shim, Jae Jeong ^a   Kang, Kyung Ho ^a   Yoo, Se Hwa ^a   Kim, Chul Hwan ^a   Kim, Han Kyeom ^a   Lee, Sang Hoon ^a   Uhm, Chang Sub ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Matrix metalloproteinase 13; Proteomics; Pulmonary disease, chronic obstructive; TXNL2 protein, human

Indexed keywords

COLLAGENASE 3; HEPATOMA DERIVED GROWTH FACTOR; HISTAMINE; RGS PROTEIN; THIOREDOXIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR AP 4; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRONCHUS MUCOSA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL TYPE 2; LUNG CANCER; LUNG PARENCHYMA; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEOMICS; SMOKING; TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

EID: 60249084174     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-1583     Document Type: Article

References (33)

1. Fletcher CM, Peto R, Tinker CM. The natural history of chronic bronchitis and emphysema. London, UK: Oxford University Press, 1976
2. Rennard SI, Vestbo J. COPD: the dangerous underestimate of 15%. Lancet 2006; 367:1216-1219
3. Pinto-Plata V, Toso J, Lee K, et al. Use of proteomic patterns of serum biomarkers in patients with chronic obstructive pulmonary disease: correlation with clinical parameters. Proc Am Thorac Soc 2006; 3:465-466
4. Merkel D, Rist W, Seither P, et al. Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface- enhanced laser desorption/ionization-mass spectrometry profling with mass spectrometric protein identification. Proteomics 2005; 5:2972-2980
5. Casado B, Iadarola P, Pannell LK, et al. Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. J Proteome Res 2007; 6:4615-4623
6. Magi B, Bini L, Perari MG, et al. Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study. Electrophoresis 2002; 23:3434-3444
7. Wattiez R, Hermans C, Cruyt C, et al. Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases. Electrophoresis 2000; 21:2703-2712
8. Wattiez R, Noel-Georis I, Cruyt C, et al. Susceptibility to oxidative stress: proteomic analysis of bronchoalveolar lavage from ozone-sensitive and ozone-resistant strains of mice. Proteomics 2003; 3:658-665
9. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-555
10. Takaishi H, Kimura T, Dalal S, et al. Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr Pharm Biotechnol 2008; 9:47-54
11. Pendas AM, Uria JA, Jimenez MG, et al. An overview of collagenase-3 expression in malignant tumors and analysis of its potential value as a target in antitumor therapies. Clin Chim Acta 2000; 291:137-155
12. Raulo SM, Sorsa TA, Kiili MT, et al. Evaluation of collagenase activity, matrix metalloproteinase-8, and matrix metalloprotemase-13 in horses with chronic obstructive pulmonary disease. Am J Vet Res 2001; 62:1142-1148
13. Wright JL, Tai H, Wang R, et al. Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-α signaling. Am J Physiol Lung Cell Mol Physiol 2007; 292: L125-133
14. Vajner L, Vytasek R, Lachmanova V, et al. Acute and chronic hypoxia as well as 7-day recovery from chronic hypoxia affects the distribution of pulmonary mast cells and their MMP-13 expression in rats. Int J Exp Pathol 2006; 87:383-391
15. Karakiulakis G, Papakonstantinou E, Aletras AJ, et al. Cell type-specific effect of hypoxia and platelet-derived growth factor-BB on extracellular matrix turnover and its consequences for lung remodeling. J Biol Chem 2007; 282:908-915
16. Woodruff PG, Koth LL, Yang YH, et al. A distinctive alveolar macrophage activation state induced by cigarette smoking.
17. Am J Respir Crit Care Med 2005; 172:1383-1392
18. Segura-Valdez L, Pardo A, Gaxiola M, et al. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000; 117:684-694
19. Vernooy JH, Lindeman JH, Jacobs JA, et al. Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD. Chest 2004; 126:1802-1810
20. Nakamura H, Nakamura K, Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 1997; 15:351-369
21. Rahman I, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J 2006; 28:219-242
22. Sadek CM, Jimenez A, Damdimopoulos AE, et al. Characterization of human thioredoxin-like 2: a novel microtubule-binding thioredoxin expressed predominantly in the cilia of lung airway epithelium and spermatid manchette and axoneme. J Biol Chem 2003; 278:13133-13142
23. Lu Y, Wang X, Liu Z, et al. Identification and distribution of thioredoxin-like 2 as the antigen for the monoclonal antibody MC3 specific to colorectal cancer. Proteomics 2008; 8:2220-2229
24. Lehtonen ST, Ohlmeier S, Kaarteenaho-Wiik R, et al. Does the oxidative stress in chronic obstructive pulmonary disease cause thioredoxin/peroxiredoxin oxidation? Antioxid Redox Signal 2008; 10:813-819
25. Ning W, Li CJ, Kaminski N, et al. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad SciUSA2004; 101:14895-14900
26. Kinnula VL. Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax 2005; 60:693-700
27. Sano H, Sata T, Nanri H, et al. Thioredoxin is associated with endotoxin tolerance in mice. Crit Care Med 2002; 30:190-194
28. Rahman I, Marwick J, Kirkham P. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-κB and pro-inflammatory gene expression. Biochem Pharmacol 2004; 68:1255-1267
29. Rahman I. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets. Curr Drug Targets Inflamm Allergy 2002; 1:291-315
30. Yamada Y, Nakamura H, Adachi T, et al. Elevated serum levels of thioredoxin in patients with acute exacerbation of asthma. Immunol Lett 2003; 86:199-205
31. Jeong HC, Lee SY, Lee EJ, et al. Proteomic analysis of peripheral T-lymphocytes in patients with asthma. Chest 2007; 132:489-496
32. Di Stefano A, Maestrelli P, Roggeri A, et al. Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am J Respir Crit Care Med 1994; 149:803-810
33. Mills PR, Davies RJ, Devalia JL. Airway epithelial cells, cytokines, and pollutants. Am J Respir Crit Care Med 1999; 160:S38-S43